“Regeneron said it will acquire 23andMe’s genomics service and its bank of 15 million customers’ personal and genetic data as part of the deal.”
Regeneron is buying 23andMe and the genetic data of 15 million people for $256 million. It promises privacy and names no enforcement. People who spat in a tube for ancestry reports are now in a drug company’s research pipeline. The bankruptcy court reviews the sale in June.